Citadel Advisors
PRXL

Citadel Advisors’s Parexel International Corp PRXL Stock Holding History

Citadel Advisors’s Portfolio PRXL Stock Details PRXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-7,000
Closed -$608K – 8450
2017
Q2 		$608K Sell
7,000
-10,200
-59% -$760K ﹤0.01% 4844
2017
Q1 		$1.08M Buy
17,200
+13,400
+353% +$886K ﹤0.01% 3877
2016
Q4 		$250K Sell
3,800
-3,500
-48% -$219K ﹤0.01% 5940
2016
Q3 		$507K Sell
7,300
-2,800
-28% -$189K ﹤0.01% 4829
2016
Q2 		$635K Buy
10,100
+1,200
+13% +$74.3K ﹤0.01% 4169
2016
Q1 		$558K Buy
8,900
+5,400
+154% +$333K ﹤0.01% 4263
2015
Q4 		$238K Sell
3,500
-5,800
-62% -$377K ﹤0.01% 5558
2015
Q3 		$576K Buy
9,300
+700
+8% +$47.1K ﹤0.01% 4608
2015
Q2 		$553K Sell
8,600
-500
-5% -$33.7K ﹤0.01% 4799
2015
Q1 		$628K Buy
9,100
+3,100
+52% +$198K ﹤0.01% 4580
2014
Q4 		$333K Buy
6,000
+600
+11% +$34.6K ﹤0.01% 5280
2014
Q3 		$341K Sell
5,400
-11,100
-67% -$633K ﹤0.01% 5106
2014
Q2 		$872K Buy
+16,500
New +$828K ﹤0.01% 3685

Other funds holding PRXL

RQS
Ramsey Quantitative Systems Louisville, Kentucky $112M AUM 16.38% 1-Year Est. Return

Citadel Advisors's PRXL Position: Q4 2017 in Review

Citadel Advisors sold out of Parexel International Corp (PRXL) in Q4 2017, closing a stake of 46,433 shares — an estimated $4.09M sold.

Citadel Advisors first reported a position in PRXL in Q2 2013 and held it in 14 quarters. The position peaked at $27M in Q1 2017. 1 fund tracked by Wall St. Rank holds PRXL as of Q4 2017.

  • Citadel Advisors reported no remaining Parexel International Corp position as of Q4 2017 after selling out during the quarter.
  • Citadel Advisors sold 46,433 Parexel International Corp shares in Q4 2017, an estimated $4.09M.
  • Citadel Advisors first reported a position in Parexel International Corp in Q2 2013 and held it in 14 quarters.
  • Citadel Advisors's Parexel International Corp position peaked at $27M in Q1 2017.
  • 1 fund tracked by Wall St. Rank held Parexel International Corp as of Q4 2017.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.